Benign Prostatic Hyperplasia Prostate Treatment Market Share

North America Market Forecast

The North America market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of market can be ascribed to the rising geriatric population, an increasing unhealthy lifestyle, and a higher prevalence of benign prostatic hyperplasia. As per the data released by the World Bank, it was represented that in 2021, the geriatric population in the USA reached 56,545,938. Furthermore, the presence of major key players, rapidly growing healthcare infrastructure of the region, coupled with the surge in novel drug delivery systems are further projected to influence the growth of the market positively over the forecast period.

Asia Pacific Market Forecast

On the other hand, the Asia Pacific region is expected to witness the fastest growth in the upcoming years, backed by the surging urological disorders cases, rising investment in the research and development for better medical facilities, and increasing demand for the benign prostatic hyperplasia (BPH) prostate treatment in the region. Furthermore, the growing population is further projected to surge the market’s growth in the region.